Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: A preliminary report on an active regimen

被引：0
|
作者：
Georgoulias, V
Kourousis, C
Kakolyris, S
Androulakis, N
Dimopoulos, MA
Papadakis, E
Kotsakis, T
Vardakis, N
Kalbakis, K
Merambeliotakis, N
Hatzidaki, D
机构：
[1] UNIV CRETE, DEPT MED ONCOL, IRAKLION, GREECE
[2] UNIV ATHENS, DEPT CLIN THERAPEUT, ATHENS, GREECE
[3] SOTIRIA GEN HOSP CHEST DIS ATHENS, DEPT PULM MED 1, ATHENS, GREECE
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 66
页数：6
相关论文
共 50 条
  • [31] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer
    Scagliotti, G
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2855 - 2866
  • [32] The safety of second-line treatment options for non-small cell lung cancer
    Rossi, Antonio
    Maione, Paolo
    Santabarbara, Giuseppe
    Sacco, Paola Claudia
    Casaluce, Francesca
    Sgambato, Assunta
    Barzelloni, Maria Luisa
    Palazzolo, Giovanni
    Gridelli, Cesare
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 471 - 479
  • [33] Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer
    Pesek, M
    Holá, V
    LUNG CANCER: CURRENT TOPICS, 2001, : 155 - 160
  • [34] Racotumomab in Non-Small Cell Lung Cancer as Maintenance and Second-Line Treatment
    Caceres-Lavernia, Haslen H.
    Neninger-Vinageras, Elia
    Varona-Rodriguez, Leslie M.
    Olivares-Romero, Yoli A.
    Sanchez-Rojas, Irlis
    Mazorra-Herrera, Zaima
    Basanta-Bergolla, Denenke
    Duvergel-Calderin, Dayanis
    Torres-Cuevas, Boris L.
    del Castillo-Carrillo, Concepcion
    MEDICC REVIEW, 2021, 23 (3-4) : 21 - 28
  • [35] Future directions in the second-line treatment of non-small cell lung cancer
    Rosell, R
    Cecere, F
    Cognetti, F
    Cuello, M
    Sanchez, JM
    Taron, M
    Reguart, N
    Jablons, D
    SEMINARS IN ONCOLOGY, 2006, 33 (01) : S45 - S51
  • [36] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [37] Non-small cell lung cancer: second-line and beyond
    Stahel, R. A.
    ANNALS OF ONCOLOGY, 2006, 17 : X97 - X100
  • [38] Second-line chemotherapy for non-small cell lung cancer
    Ruckdeschel, JC
    CHEST, 2006, 129 (04) : 840 - 842
  • [39] From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?
    Ettore D’Argento
    Sabrina Rossi
    Giovanni Schinzari
    Antonia Strippoli
    Michele Basso
    Alessandra Cassano
    Carlo Barone
    Current Treatment Options in Oncology, 2016, 17
  • [40] Pharmacoeconomic analysis of erlotinib as second-line treatment of advanced non-small cell lung cancer in Taiwan
    Hsia, T.
    Chang, G.
    Chen, Y.
    Lin, M.
    Su, W.
    Tsai, C.
    Tsai, C.
    Yang, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 375 - 375
12345